Pharmacy-benefit manager Express Scripts will soon make an adjustment that raises out-of-pocket costs for some customers filling prescriptions of Pfizer’s cholesterol-lowering drug Lipitor, underscoring the drug maker’s challenge of keeping sales high in the face of generic competition. Read more…
The FDA approved Amylin Pharmaceuticals’ diabetes drug Bydureon after a prolonged regulatory process to address safety concerns. Read more…
WASHINGTON (Reuters) – Health regulators on Friday detained nine shipments of orange juice from Brazil and Canada that contained traces of an illegal fungicide, and rejected industry calls to overhaul the way they test for the banned substance.
FRIDAY, Jan. 27 — Bydureon (exenatide extended release), Amylin Pharmaceuticals’ long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Administration.The once-weekly injection will include a label warning…
FRIDAY, Jan. 27 — Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven’t responded to another drug.Renal cell carcinoma is a form of kidney cancer that begins in…